Daniel E. Hall

Daniel E. Hall

Auto-generated profile, based on publicly available information

Daniel E. Hall

Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2017 in JAMA Surgery
Verified
Journal Article
Open access
PDF file
DHDaniel E. Hall
Daniel E. Hall
SAShipra Arya
Shipra Arya
KSKendra K. Schmid
Kendra K. Schmid
CBCasey Blaser
Casey Blaser
MCMark A. Carlson
Mark A. Carlson
JJJason Johanning
Jason Johanning
Frailty is a geriatric concept identifying those patients (regardless of age) at increased risk of dying in 6 months to 5 years owing to a decline in physiologic reserve.1-6 This decline in physiologic reserve has important implications for the surgical patient because a diagnosis of frailty is associated with markedly increased risks for postoperative mortality and morbidity. For example, when compared with robust patients, frail surgical patients are less likely to be discharged to home,7 more likely to be readmitted within 30 days,8,9 and have substantially increased rates of perioperative mortality and complications.9-13 Given these data, growing consensus suggests that frailty-associated risks should inform shared decision making and lead to discussions clarifying realistic goals of care.

1 January 2020 in JAMA Surgery
Verified
Journal Article
Open access
PDF file
MSMyrick C. Shinall
Myrick C. Shinall
SAShipra Arya
Shipra Arya
AYAda Youk
Ada Youk
PVPatrick Varley
Patrick Varley
RSRupen Shah
Rupen Shah
DHDaniel E. Hall
Daniel E. Hall
Research shows that frailty among patients preoperatively is associated with postoperative outcomes.1-4 Patients who are frail have higher rates of morbidity, mortality, and failure to rescue after major procedures across surgical specialties.5-16 Patients who are frail also have higher rates of morbidity after ambulatory procedures typically considered to be minor.17 Thus, frailty is a salient, potentially modifiable patient characteristic in surgical practice.18-21

5 March 2012 in Canadian Medical Association Journal
Verified
Journal Article
Open access
PDF file
DHDaniel E. Hall
Daniel E. Hall
APAllan V. Prochazka
Allan V. Prochazka
AFAaron S. Fink
Aaron S. Fink
Lthough informed consent for clinical treatment has become a vital part of contemporary medical practice, it means different things in different contexts (Figure 1), is variably practised and rarely achieves the theoretical ideal. In this review, we focus on the clinical practice of informed consent. We first describe what we know about informed consent: what it is, where it came from and what purposes it serves. We then describe several limitations that complicate the practice of informed consent. Finally, we make several practical suggestions as to how clinicians might optimally approach the informed consent process. A summary of the evidence used in this re view is available in Box 1. 1 Although we had hoped to identify high-quality studies that would provide a strong quantitative base of evidence for recommendations around informed consent, much of the quantitative literature on this topic is descriptive in nature. Informed consent is primarily a legal and ethical concept; although often informed by data, the standards of scholarship in law and ethics focus on the strength of analytical argument rather than the weight of empirical data. Therefore, we sought to synthesize the available knowledge on this subject, re ferencing empirical data when possible, summarizing relevant arguments that are particularly prevalent, persuasive or insightful. This article has been peer reviewed.

1 March 2017 in JAMA Surgery
Verified
Journal Article
Open access
PDF file
DHDaniel E. Hall
Daniel E. Hall
SAShipra Arya
Shipra Arya
KSKendra K. Schmid
Kendra K. Schmid
MCMark A. Carlson
Mark A. Carlson
PLPierre Lavedan
Pierre Lavedan
JJJason M. Johanning
Jason M. Johanning
Many patients older than 65 years undergo surgery.1 For some, surgery will confer substantial benefits (eg, extended life, improved quality of life). For others, surgery will confer burdens for patients, families, and society at large (eg, pain, distress, increased inpatient admissions, institutionalization, financial hardship, and increased health care costs).2,3 Thus, there is an imperative to identify patients at greatest risk for harm, ensure their decision-making process regarding surgery is patient centered, and provide tailored clinical care to improve surgical outcomes in high-risk patients.

1 September 2011 in Annals of Surgery
Verified
Journal Article
Closed access
MNMatthew D. Neal
Matthew D. Neal
JAJohn C. Alverdy
John C. Alverdy
DHDaniel E. Hall
Daniel E. Hall
RSRichard L. Simmons
Richard L. Simmons
BZBrian S. Zuckerbraun
Brian S. Zuckerbraun
To determine whether a minimally invasive, colon-preserving approach could serve as an alternative to total colectomy in the treatment of severe, complicated Clostridium difficile-associated disease (CDAD). C. difficile is a significant cause of morbidity and mortality worldwide. Most cases will respond to antibiotic therapy, but 3% to 10% of patients progress to a severe, complicated, or "fulminant" state of life-threatening systemic toxicity. Although the advocated surgical treatment of total abdominal colectomy with end ileostomy improves survival in severe, complicated CDAD, outcomes remain poor with associated mortality rates ranging from 35% to 80%. All patients who were diagnosed with severe, complicated ("fulminant") CDAD and were treated at the University of Pittsburgh Medical Center or VA Pittsburgh Healthcare System between June 2009 and January 2011 were treated with this novel approach. The surgical approach involved creation of a loop ileostomy, intraoperative colonic lavage with warmed polyethylene glycol 3350/electrolyte solution via the ileostomy and postoperative antegrade instillation of vancomycin flushes via the ileostomy. The primary end point for the study was resolution of CDAD. The matching number of patients treated with colectomy for CDAD preceding the initiation of this current treatment strategy was analyzed for historical comparison. Forty-two patients were treated during this time period. There was no significant difference in age, sex, pharmacologic immunosuppression, and Acute Physiology and Chronic Health Evaluation-II scores between our current cohort and historical controls. The operation was accomplished laparoscopically in 35 patients (83%). This treatment strategy resulted in reduced mortality compared to our historical population (19% vs 50%; odds ratio, 0.24; P = 0.006). Preservation of the colon was achieved in 39 of 42 patients (93%). Loop ileostomy and colonic lavage are an alternative to colectomy in the treatment of severe, complicated CDAD resulting in reduced morbidity and preservation of the colon.

20 March 2019 in Annals of Surgery
Verified
Journal Article
Closed access
SAShipra Md Arya
Shipra Md Arya
PVPatrick Varley
Patrick Varley
AYAda Youk
Ada Youk
JBJeffrey D. Borrebach
Jeffrey D. Borrebach
SPSebastian Perez
Sebastian Perez
DHDaniel E. Md Hall
Daniel E. Md Hall
Objective and Background: The Risk Analysis Index (RAI) predicts 30-, 180-, and 365-day mortality based on variables constitutive of frailty. Initially validated, in a single-center Veteran hospital, we sought to improve model performance by recalibrating the RAI in a large, veteran surgical registry, and to externally validate it in both a national surgical registry and a cohort of surgical patients for whom RAI was measured prospectively before surgery. Methods: The RAI was recalibrated among development and confirmation samples within the Veterans Affairs Surgical Quality Improvement Program (VASQIP; 2010–2014; N = 480,731) including major, elective noncardiac surgery patients to create the revised RAI (RAI-rev), comparing discrimination and calibration. The model was tested externally in the American College of Surgeons National Surgical Quality Improvement Program dataset (NSQIP; 2005–2014; N = 1,391,785), and in a prospectively collected cohort from the Nebraska Western Iowa Health Care System VA (NWIHCS; N = 6,856). Results: Recalibrating the RAI significantly improved discrimination for 30-day [c = 0.84–0.86], 180-day [c = 0.81–0.84], and 365-day mortality [c = 0.78–0.82] (P < 0.001 for all) in VASQIP. The RAI-rev also had markedly better calibration (median absolute difference between observed and predicted 180-day mortality: decreased from 8.45% to 1.23%). RAI-rev was highly predictive of 30-day mortality (c = 0.87) in external validation with excellent calibration (median absolute difference between observed and predicted 30-day mortality: 0.6%). The discrimination was highly robust in men (c = 0.85) and women (c = 0.89). Discrimination also improved in the prospectively measured cohort from NWIHCS for 180-day mortality [c = 0.77 to 0.80] (P < 0.001). Conclusions: The RAI-rev has improved discrimination and calibration as a frailty-screening tool in surgical patients. It has robust external validity in men and women across a wide range of surgical settings and available for immediate implementation for risk assessment and counseling in preoperative patients.